- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sakar Healthcare reports Q2 revenue up 34.6% YoY to ₹57.56 Cr & H1 revenue up 31.4% to ₹110.30 Cr, with H1 PAT up 27.8% to ₹9.21 Cr. Company advances oncology portfolio with 49 agreements & a ~₹452 Cr business plan, expanding globally.